Transglutaminase-Based Chemo-Enzymatic Conjugation Approach Yields Homogeneous Antibody–Drug Conjugates

化学 马来酰亚胺 结合 组合化学 酶 基质(水族馆) 化学稳定性 硫醇 产量(工程) 组织谷氨酰胺转胺酶 化学改性 叠氮化物 抗体 肽 同种类的 娴熟的 立体化学 有机化学 生物化学 数学分析 海洋学 材料科学 数学 免疫学 冶金 生物 地质学 物理 热力学
作者
Patrick Dennler,Aristeidis Chiotellis,Eliane Fischer,Delphine Brégeon,Christian Belmant,Laurent Gauthier,Florence Lhospice,François Romagné,Roger Schibli
出处
期刊:Bioconjugate Chemistry [American Chemical Society]
卷期号:25 (3): 569-578 被引量:321
标识
DOI:10.1021/bc400574z
摘要

Most chemical techniques used to produce antibody-drug conjugates (ADCs) result in a heterogeneous mixture of species with variable drug-to-antibody ratios (DAR) which will potentially display different pharmacokinetics, stability, and safety profiles. Here we investigated two strategies to obtain homogeneous ADCs based on site-specific modification of deglycosylated antibodies by microbial transglutaminase (MTGase), which forms isopeptidic bonds between Gln and Lys residues. We have previously shown that MTGase solely recognizes Gln295 within the heavy chain of IgGs as a substrate and can therefore be exploited to generate ADCs with an exact DAR of 2. The first strategy included the direct, one-step attachment of the antimitotic toxin monomethyl auristatin E (MMAE) to the antibody via different spacer entities with a primary amine functionality that is recognized as a substrate by MTGase. The second strategy was a chemo-enzymatic, two-step approach whereby a reactive spacer entity comprising a bio-orthogonal thiol or azide function was attached to the antibody by MTGase and subsequently reacted with a suitable MMAE-derivative. To this aim, we investigated two different chemical approaches, namely, thiol-maleimide and strain-promoted azide-alkyne cycloaddition (SPAAC). Direct enzymatic attachment of MMAE-spacer derivatives at an 80 molar excess of drug yielded heterogeneous ADCs with a DAR of between 1.0 to 1.6. In contrast to this, the chemo-enzymatic approach only required a 2.5 molar excess of toxin to yield homogeneous ADCs with a DAR of 2.0 in the case of SPAAC and 1.8 for the thiol-maleimide approach. As a proof-of-concept, trastuzumab (Herceptin) was armed with the MMAE via the chemo-enzymatic approach using SPAAC and tested in vitro. Trastuzumab-MMAE efficiently killed BT-474 and SK-BR-3 cells with an IC50 of 89.0 pM and 21.7 pM, respectively. Thus, the chemo-enzymatic approach using MTGase is an elegant strategy to form ADCs with a defined DAR of 2. Furthermore, the approach is directly applicable to a broad variety of antibodies as it does not require prior genetic modifications of the antibody sequence.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
行走的荷尔蒙的应助被依山尽采纳,获得30
1秒前
1秒前
1秒前
论文小能手完成签到 ,获得积分10
1秒前
CodeCraft的应助被冷酷成风采纳,获得10
1秒前
上官若男的应助被含糊的翠曼采纳,获得10
2秒前
2秒前
2秒前
NexusExplorer的应助被细腻驳采纳,获得10
3秒前
CipherSage的应助被SCW采纳,获得10
3秒前
5秒前
5秒前
sdl发布了新的文献求助10
6秒前
Orange的应助被li采纳,获得10
6秒前
6秒前
Liwx关注了科研通微信公众号
7秒前
7秒前
小马甲的应助被罗小黑采纳,获得10
8秒前
9秒前
Orange的应助被lili采纳,获得10
10秒前
正直未来发布了新的文献求助10
11秒前
完美世界的应助被鸭鸭采纳,获得10
11秒前
12秒前
12秒前
Angleli完成签到,获得积分10
12秒前
SRJ发布了新的文献求助30
13秒前
瓦学弟的妈妈完成签到,获得积分10
14秒前
英俊的铭的应助被平常马里奥采纳,获得10
15秒前
细腻驳发布了新的文献求助10
15秒前
金金金完成签到,获得积分10
15秒前
null的应助被生动万言采纳,获得10
16秒前
17秒前
11完成签到,获得积分10
18秒前
土豆完成签到 ,获得积分10
18秒前
19秒前
zhiyuanli完成签到,获得积分10
20秒前
21秒前
21秒前
陈亦完成签到 ,获得积分10
21秒前
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175157
求助须知:如何正确求助?哪些是违规求助? 9566975
关于积分的说明 21789458
捐赠科研通 7769647
什么是DOI,文献DOI怎么找? 3431836
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477241